| Literature DB >> 17097559 |
Aniruddha J Deshpande1, Monica Cusan, Vijay P S Rawat, Hendrik Reuter, Alexandre Krause, Christiane Pott, Leticia Quintanilla-Martinez, Purvi Kakadia, Florian Kuchenbauer, Farid Ahmed, Eric Delabesse, Meinhard Hahn, Peter Lichter, Michael Kneba, Wolfgang Hiddemann, Elizabeth Macintyre, Cristina Mecucci, Wolf-Dieter Ludwig, R Keith Humphries, Stefan K Bohlander, Michaela Feuring-Buske, Christian Buske.
Abstract
A challenge for the development of therapies selectively targeting leukemic stem cells in acute myeloid leukemia (AML) is their similarity to normal hematopoietic stem cells (HSCs). Here we demonstrate that the leukemia-propagating cell in murine CALM/AF10-positive AML differs from normal HSCs by B220 surface expression and immunoglobulin heavy chain rearrangement. Furthermore, depletion of B220+ cells in leukemic transplants impaired development of leukemia in recipients. As in the murine model, human CALM/AF10-positive AML was characterized by CD45RA (B220)-positive, IG DH-JH rearranged leukemic cells. These data demonstrate in a murine leukemia model that AML can be propagated by a transformed progenitor with lymphoid characteristics, which can be targeted by antibodies that do not crossreact with normal HSCs.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17097559 DOI： 10.1016/j.ccr.2006.08.023
Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743